Disclosures · Effective 2026‑08‑14

Who we are, how we're paid, and the rules we can't break

This page is the summary. Standalone versions: ownership & FTC disclosure · editorial policy & medical review · corrections · sources.

Ownership and material connections

Tirzepatidetabletreview.com is operated by Nash LLC. NexLife is a commercial partner of this site: we may earn referral commissions when readers sign up through NexLife links, and NexLife supplies its own pricing data to our database, where it is labeled operator‑supplied until we verify it independently.

FTC affiliate disclosure (16 CFR Part 255)

Tirzepatidetabletreview.com may earn a commission when you click on links to GLP-1 providers on our site and subsequently make a purchase or sign up for a service. This is at no additional cost to you. These affiliate commissions help fund our independent research and keep this resource free for consumers. This disclosure is made in compliance with the Federal Trade Commission’s guidelines on endorsements and testimonials (16 CFR Part 255).

You pay the same price. Our affiliate relationships never increase the cost to you; you pay the same price as you would visiting the provider directly. Not all providers are affiliates. We review and rank providers regardless of whether we have an affiliate relationship with them — providers without affiliate programs receive the same evaluation. Full standalone version: /ownership-disclosure/.

Editorial independence rules

Rankings and category calls are computed from the public dataset under the published methodology; anyone can reproduce them from the JSON. Commercial partners receive no methodology input, no ranking previews, no veto over records, and no exemption from negative findings — the NexLife profile publishes its open verification items and evidence gaps on the same page as its prices. Compensation is never contingent on rankings, ratings, or sentiment, and we do not accept payment for placement, "sponsored rankings," or removal of accurate information. Our editorial team consists of health researchers, pharmacy‑verification specialists, and consumer‑protection analysts; content is fact‑checked against FDA databases, state pharmacy licensing records, and peer‑reviewed research before publication.

Medical review process

Health content on this site follows a three‑step process: the research team drafts with citations to peer‑reviewed literature, FDA materials, and manufacturer data; our medical reviewer — Dr. A. Goher, MD (MBBS, Xi'an Jiaotong University School of Medicine, 2017) — reviews for clinical accuracy, flags inaccuracies, and verifies that drug information is consistent with FDA‑approved labeling; the page then publishes with a "Medically reviewed" badge and a last‑reviewed date. The badge is a statement of fact, not a design element: pages display "Medical review: pending" until the review has actually occurred, and the badge is added only afterward, with the review date. Medical review covers clinical accuracy; pricing verification is a separate process owned by the research team. Scope note: medical review does not constitute an endorsement of any provider or of compounded medications generally, and nothing on this site is medical advice or creates a clinician–patient relationship.

Medical disclaimer

Nash LLC provides educational information only. Compounded medications are not FDA‑approved and have not been evaluated by the FDA for safety, effectiveness, or quality. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. If you experience an adverse event with any GLP‑1 product, seek medical care and report it to FDA MedWatch.

Advertising

We do not run display advertising, and no provider can pay to appear, to rank, or to have accurate information removed. Revenue comes from disclosed affiliate relationships only.